Iris Dorbian

INKEF appoints Bulthuis as MD and head of healthcare team

INKEF Capital, a Dutch venture firm, has named Roel Bulthuis as managing director and head of healthcare team. Previously, he worked at M Ventures.

ISIF, WuXi and GMI launch $400 mln program to boost Ireland as genomics research hub

The Ireland Strategic Investment Fund, WuXi NextCODE and Genomics Medicine Ireland have launched a $400 million investment program aimed at making Ireland a hub for genomics research and development of new disease treatments and cures. The other investors in this initiative include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital.

VC-backed Rgenix expands board with new addition

New York City-based Rgenix, Inc, a developer of small molecule and antibody cancer therapeutics, has named Dr. Peter Van Vlasselaer to its board of directors. Recently, he was the president and CEO of ARMO Biosciences. Rgenix's backers include Novo A/S, Sofinnova Partners, Lepu Medical, Oceanpine Capital, WuXi AppTec’s Corporate Venture Fund, Alexandria Venture Investments and the Partnership Fund for New York City’s Innovate NY Fund.

Signal Peak Ventures taps Dahl as MD

Signal Peak Ventures has appointed Ben Dahl as a managing director. Previously, Dahl worked at Pelion Venture Partners where he was a partner.

Frazier Healthcare Partners recruits Hancock as senior adviser

Frazier Healthcare Partners has named Dr. Mimi Hancock to its life sciences team as a senior adviser. Previously, she was a member of Spencer Stuart's life sciences practice.

Oral health company Quip picks up $40 mln

Brooklyn, New York-based Quip, an oral health company, has secured $40 million in funding. The lead investor was Sherpa Capital.

Gaorong collects $450 mln for fourth fund

Chinese venture firm Gaorong Capital has raised $450 million for its fourth fund, according to an SEC filing. Gaorong Capital focuses on early and growth stage investments in TMT, including AI and frontier technologies, consumption and retail, fintech and enterprise services.

Prose locks in $18 mln Series B

New York City and Paris-based Prose, a maker of hair care products, has raised $18 million in Series B financing. Insight Venture Partners led the round with participation from return backers Forerunner Ventures, ISAI, Lerer Hippeau Ventures and Correlation Ventures.

Robolab backs robotic bartender Yanu

Estonia-based Yanu, a AI-powered robotic bartender, has secured $1 million in funding, according to a source at the firm. The investor was Robolab.

Rheostat Therapeutics inks $23 mln Series A

Cambridge, Massachusetts-based Rheostat Therapeutics, a biotech company focused on treating neurodegeneration, cognition and rare diseases, has raised $23 million in Series A financing. MRLV and AbbVie Ventures led the round.